Cordlife Group P8A.SI · SGD

Its shares trade on SGX under the ticker P8A.SI. It has been listed since 29 March 2012. In the fiscal year to 31 December 2025, it reported revenue of SGD 38.9m and a net loss of SGD 12.6m. At that date it held total assets of SGD 201.8m and shareholders' equity of SGD 104.3m.

Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood banking services. The company employs 111 full-time employees The company went IPO on 2012-03-29. The firm operates as a consumer healthcare company. Its segments include Banking, Diagnostic and Others. The banking segment comprises cord blood and cord lining services. The diagnostics segment comprises Metascreen, which is a metabolic screening test specially designed for newborn babies, non-invasive prenatal testing service, and Eyescreen, a noninvasive pediatric eye-screening service. The cord blood and cord lining are collected, processed and stored in the various laboratories in the regions that the Company operates in. The firm also releases cord blood units for transplants, and for the treatment of cerebral palsy, as well as for other therapeutic uses. The company has processing and cryopreservation storage facilities across Asia, namely in Singapore, Hong Kong, India, Indonesia, Malaysia and the Philippines.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Lingyun ZhaiExecutive Chairman of the Board, since 2019
• Ms. Xiaoling ChenGroup Chief Executive Officer, Group Executive Director, since 2021
• Ms. Xun Er GohGroup Chief Financial Officer, Joint Company Secretary, since 2025
• Ms. Yifei WuGroup Chief Financial Officer
• Ms. Hui Yee CheokJoint Company Secretary
• Ms. Xiaorui WangNon-Executive Director
• Mr. Ming Yiu YiuNon-Independent Non-Executive Director
• Mr. Xiang GaoNon-Executive Independent Director
• Mr. Sze Kuan SimNon-Executive Independent Director
• Dr. Tianhong XuNon-Executive Independent Director
• Ms. Wai YuenNon-Executive Independent Director
• Kamal SamuelDirector, since 2014

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.